Hippocampal HDAC4 contributes to postnatal fluoxetine-evoked depression-like behavior

Neuropsychopharmacology

Volumn 39, Issue 9, 2014, Pages 2221-2232

  Sarkar, Ambalika ^a   Chachra, Parul ^a   Kennedy, Pamela ^b   Pena, Catherine J ^b   Desouza, Lynette A ^a   Nestler, Eric J ^b   Vaidya, Vidita A ^a  

^a TATA INSTITUTE OF FUNDAMENTAL RESEARCH   (India)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; FLUOXETINE; HISTONE DEACETYLASE 4; HYPERPOLARIZATION ACTIVATED CYCLIC NUCLEOTIDE GATED CHANNEL; MAMMALIAN TARGET OF RAPAMYCIN; TRANSCRIPTOME; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; HDAC4 PROTEIN, RAT; HISTONE DEACETYLASE;

ADOLESCENCE; ADULTHOOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DEPRESSION; DNA BINDING; EMOTIONALITY; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION; HIPPOCAMPUS; HISTONE ACETYLATION; IMMOBILITY; LATENT PERIOD; MALE; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; RETREATMENT; TRANSCRIPTION REGULATION; UPREGULATION; AGING; ANIMAL; ANXIETY DISORDERS; CHEMICALLY INDUCED; DEPRESSIVE DISORDER; DRUG EFFECTS; EMOTION; FEMALE; GROWTH, DEVELOPMENT AND AGING; METABOLISM; NEWBORN; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TOXICITY;

AGING; ANIMALS; ANIMALS, NEWBORN; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANXIETY DISORDERS; BUTYRIC ACID; DEPRESSIVE DISORDER; EMOTIONS; FEMALE; FLUOXETINE; GENE EXPRESSION; HIPPOCAMPUS; HISTAMINE ANTAGONISTS; HISTONE DEACETYLASES; MALE; RATS, SPRAGUE-DAWLEY; TRANSCRIPTOME;

EID: 84904504172     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.73     Document Type: Article

References (50)

1. Ajamian F, Salminen A, Reeben M (2004). Selective regulation of class I and class II histone deacetylases expression by inhibitors of histone deacetylases in cultured mouse neural cells. Neurosci Lett 365: 64-68.
2. Ansorge MS, Zhou M, Lira A, Hen R, Gingrich JA (2004). Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 306: 879-881.
3. Ansorge MS, Morelli E, Gingrich JA (2008). Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice. J Neurosci 28: 199-207.
4. Benekareddy M, Goodfellow NM, Lambe EK, Vaidya VA (2010). Enhanced function of prefrontal serotonin 5-HT(2) receptors in a rat model of psychiatric vulnerability. J Neurosci 30: 12138-12150.
5. Benjamini Y, Hochberg Y (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 57: 289-300.
6. Bookout AL, Mangelsdorf DJ (2003). Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways. Nucl Recept Signal 1: e102.
7. Brambilla P, Cipriani A, Hotopf M, Barbui C (2005). Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis of clinical trial data. Pharmacopsychiatry 38: 69-77.
8. Christiansen SH, Olesen MV, Wortwein G, Woldbye DP (2011). Fluoxetine reverts chronic restraint stress-induced depressionlike behaviour and increases neuropeptide Y and galanin expression in mice. Behav Brain Res 216: 585-591.
9. Clark MS, Sexton TJ, McClain M, Root D, Kohen R, Neumaier JF (2002). Overexpression of 5-HT1B receptor in dorsal raphe nucleus using Herpes Simplex virus gene transfer increases anxiety behavior after inescapable stress. J Neurosci 22: 4550-4562.
10. Conti B, Maier R, Barr AM, Morale MC, Lu X, Sanna PP et al (2007). Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine. Mol Psychiatry 12: 167-189.
11. Deacon RM, Bannerman DM, Rawlins JN (2002). Anxiolytic effects of cytotoxic hippocampal lesions in rats. Behav Neurosci 116: 494-497.
12. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC et al (2003). DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: 3.
13. Dulawa SC, Holick KA, Gundersen B, Hen R (2004). Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology 29: 1321-1330.
14. Gipson TT, Johnston MV (2012). Plasticity and mTOR: towards restoration of impaired synaptic plasticity in mTOR-related neurogenetic disorders. Neural Plast 2012: 486402.
15. Hisaoka K, Nishida A, Koda T, Miyata M, Zensho H, Morinobu S et al (2001). Antidepressant drug treatments induce glial cell line-derived neurotrophic factor (GDNF) synthesis and release in rat C6 glioblastoma cells. J Neurochem 79: 25-34.
16. Hobara T, Uchida S, Otsuki K, Matsubara T, Funato H, Matsuo K et al (2010). Altered gene expression of histone deacetylases in mood disorder patients. J Psychiatr Res 44: 263-270.
17. Holmes A, Murphy DL, Crawley JN (2003). Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression. Biol Psychiatry 54: 953-959.
18. Homberg JR, Schiepers OJ, Schoffelmeer AN, Cuppen E, Vanderschuren LJ (2007). Acute and constitutive increases in central serotonin levels reduce social play behaviour in peri-adolescent rats. Psychopharmacology (Berl) 195: 175-182.
19. Homberg JR, Olivier JD, Blom T, Arentsen T, van Brunschot C, Schipper P et al (2011). Fluoxetine exerts age-dependent effects on behavior and amygdala neuroplasticity in the rat. PLoS One 6: e16646.
20. Iga J, Ueno S, Yamauchi K, Numata S, Kinouchi S, Tayoshi- Shibuya S et al (2007). Altered HDAC5 and CREB mRNA expressions in the peripheral leukocytes of major depression. Prog Neuropsychopharmacol Biol Psychiatry 31: 628-632.
21. Iñiguez SD, Warren BL, Bolaños-Guzmán CA (2010). Short- and long-term functional consequences of fluoxetine exposure during adolescence in male rats. Biol Psychiatry 67: 1057-1066.
22. Jernigan CS, Goswami DB, Austin MC, Iyo AH, Chandran A, Stockmeier CA et al (2011). The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 35: 1774-1779.
23. Karpova NN, Lindholm J, Pruunsild P, Timmusk T, Castren E (2009). Long-lasting behavioural and molecular alterations induced by early postnatal fluoxetine exposure are restored by chronic fluoxetine treatment in adult mice. Eur Neuropsychopharmacol 19: 97-108.
24. Kheirbek MA, Drew LJ, Burghardt NS, Costantini DO, Tannenholz L, Ahmari SE et al (2013). Differential control of learning and anxiety along the dorsoventral axis of the dentate gyrus. Neuron 77: 955-968.
25. Kim HJ, Leeds P, Chuang DM (2009). The HDAC inhibitor, sodium butyrate, stimulates neurogenesis in the ischemic brain. J Neurochem 110: 1226-1240.
26. Kim MS, Akhtar MW, Adachi M, Mahgoub M, Bassel-Duby R, Kavalali ET et al (2012). An essential role for histone deacetylase 4 in synaptic plasticity and memory formation. J Neurosci 32: 10879-10886.
27. Kiryanova V, Smith VM, Dyck RH, Antle MC (2013). The effects of perinatal fluoxetine treatment on the circadian system of the adult mouse. Psychopharmacology 225: 743-751.
28. Kodish I, Rockhill C, Varley C (2011). Pharmacotherapy for anxiety disorders in children and adolescents. Dialogues Clin Neurosci 13: 439-452.
29. Kohl Z, Winner B, Ubhi K, Rockenstein E, Mante M, Münch M et al (2012). Fluoxetine rescues impaired hippocampal neurogenesis in a transgenic A53T synuclein mouse model. Eur J Neurosci 35: 10-19.
30. Kramer OH, Zhu P, Ostendorff HP, Golebiewski M, Tiefenbach J, Peters MA et al (2003). The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. EMBO J 22: 3411-3420.
31. Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M et al (2010). mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329: 959-964.
32. Lira A, Zhou M, Castanon N, Ansorge MS, Gordon JA, Francis JH et al (2003). Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporterdeficient mice. Biol Psychiatry 54: 960-971.
33. Maciag D, Simpson KL, Coppinger D, Lu Y, Wang Y, Lin RC et al (2006). Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry. Neuropsychopharmacology 31: 47-57.
34. Miller BH, Schultz LE, Gulati A, Cameron MD, Pletcher MT (2008). Genetic regulation of behavioral and neuronal responses to fluoxetine. Neuropsychopharmacology 33: 1312-1322.
35. Narboux-Nême N, Pavone LM, Avallone L, Zhuang X, Gaspar P (2008). Serotonin transporter transgenic (SERTcre) mouse line reveals developmental targets of serotonin specific reuptake inhibitors (SSRIs). Neuropharmacology 55: 994-1005.
36. Nibuya M, Morinobu S, Duman RS (1995). Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15: 7539-7547.
37. Norcross M, Mathur P, Enoch AJ, Karlsson RM, Brigman JL, Cameron HA et al (2008). Effects of adolescent fluoxetine treatment on fear-, anxiety- or stress-related behaviors in C57BL/6J or BALB/cJ mice. Psychopharmacology 200: 413-424.
38. Olivier JD, Blom T, Arentsen T, Homberg JR (2011). The agedependent effects of selective serotonin reuptake inhibitors in humans and rodents: a review. Prog Neuropsychopharmacol Biol Psychiatry 35: 1400-1408.
39. Popa D, Lena C, Alexandre C, Adrien J (2008). Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: evidence from sleep, stress, and behavior. J Neurosci 28: 3546-3554.
40. Renthal W, Maze I, Krishnan V, Covington HE 3rd, Xiao G, Kumar A et al (2007). Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli. Neuron 56: 517-529.
41. Saarelainen T, Hendolin P, Lucas G, Koponen E, Sairanen M, MacDonald E et al (2003). Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J Neurosci 23: 349-357.
42. Sailaja BS, Cohen-Carmon D, Zimmerman G, Soreq H, Meshorer E (2012). Stress-induced epigenetic transcriptional memory of acetylcholinesterase by HDAC4. Proc Natl Acad Sci USA 109: E3687-E3695.
43. Sairanen M, Lucas G, Ernfors P, Castren M, Castren E (2005). Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J Neurosci 25: 1089-1094.
44. Sando R, Gounko N, Pieraut S, Liao L, Yates J 3rd, Maximov A (2012). HDAC4 governs a transcriptional program essential for synaptic plasticity and memory. Cell 151: 821-834.
45. Schroeder FA, Lin CL, Crusio WE, Akbarian S (2007). Antidepressant- like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatry 62: 55-64.
46. Silva CM, Goncalves L, Manhaes-de-Castro R, Nogueira MI (2010). Postnatal fluoxetine treatment affects the development of serotonergic neurons in rats. Neurosci Lett 483: 179-183.
47. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ (2006). Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 9: 519-525.
48. Ward RK, Zamorski MA (2002). Benefits and risks of psychiatric medications during pregnancy. Am Fam Physician 66: 629-636.
49. Warren BL, Iñiguez SD, Alcantara LF, Wright KN, Parise EM, Weakley SK et al (2011). Juvenile administration of concomitant methylphenidate and fluoxetine alters behavioral reactivity to reward- and mood-related stimuli and disrupts ventral tegmental area gene expression in adulthood. J Neurosci 31: 10347-10358.
50. Wang H, Doering LC (2013). Reversing autism by targeting downstream mTOR signaling. Front Cell Neurosci 7: 28.